When investors talk about combining fundamental strength with technical timing, they are describing a strategy that uses financials to decide what to buy and charts to decide when to buy it. The screen that flagged LivaNova Plc (NASDAQ:LIVN) is built exactly on that principle. It starts by filtering for companies showing strong earnings and revenue growth, decent profitability, and a healthy balance sheet. Then it overlays a technical filter looking for stocks that are forming constructive chart patterns—think consolidations, tight price ranges, or bullish breakouts from bases. The idea is simple: you want a business that is genuinely expanding, but you also want to buy it at a moment when the market is starting to reward that expansion again. LivaNova currently checks both boxes.
[stock-image]
Recent Performance
LivaNova has been on a strong run. Over the past six months, the stock has gained roughly 35.6%, and over the last twelve months it has surged approximately 78.3%. That kind of performance places it among the better-performing stocks in the entire market, outperforming 91% of all names. More importantly, the gains have been spread steadily over the period rather than coming in a single parabolic spike, which suggests institutional accumulation rather than speculative frenzy.
The stock is currently trading near its 52-week high of $83.98, while the S&P 500 sits in the upper part of its own 52-week range but not at new highs. That relative strength—LivaNova leading, not just following the index—is a hallmark of the kind of leadership that growth investors look for. The short-term and long-term trends are both positive, and the stock is currently above its rising 20-, 50-, 100-, and 200-day moving averages.
Technical Setup
The technical rating is a perfect 10 out of 10, and the setup rating scores a 7. What does that mean in practice? The stock has been consolidating in a relatively tight range in recent weeks, with reduced volatility. That quiet period after a strong advance often represents a pause where big money accumulates shares without pushing the price higher too quickly. The setup report identifies a "Pocket Pivot" signal, a price/volume accumulation pattern that occurs when price moves up on volume exceeding the maximum down volume from the previous ten days. That is a classic momentum-buying signal.
The suggested entry point is a buy stop order just above the ten-day high at $83.99, with a stop loss placed below the ten-day low at $77.70. That puts the maximum risk on the trade at roughly 7.5%. For a stock with this kind of trend strength and a well-defined support zone between $71.33 and $72.36, that risk-reward profile is reasonable for a growth-oriented trade. You can review the full breakdown of the technical indicators in the detailed report here.
Fundamental Strength
The fundamental rating is a solid 6 out of 10, but the composition of that score is what matters for a growth investor. The growth sub-rating comes in at 7 out of 10, and it is driven by concrete numbers:
- Earnings per share grew 13.64% over the past year and have compounded at an average rate of 25.16% annually over the previous five years.
- Revenue grew 12.39% in the last year, with an average annual growth rate of 8.24%.
- Forward earnings growth is expected to average 18.62% per year, while revenue growth is projected at 8.64% annually.
That sales and earnings trajectory is exactly what a growth screen is hunting for. The strategy we outlined at the start demands that the business itself is expanding, not just the stock price. LivaNova delivers on that front. The profitability rating of 7 is also encouraging: return on equity (8.85%), return on invested capital (8.01%), and operating margins (13.68%) all rank in the top quartile of the Health Care Equipment & Supplies industry.
Valuation and Health Considerations
No growth stock is without trade-offs. The valuation rating is a 4, which reflects a P/E ratio of 20.56—not cheap, but actually below the S&P 500 average of 27.43 and significantly cheaper than the industry median. The PEG ratio suggests that growth is not fully compensating for the multiple yet, but that is a common tension in growth investing: you pay up for quality, and the hope is that earnings growth will eventually justify the entry price.
On the health side, the rating is a 5. The company has a manageable debt-to-equity ratio of 0.24, and its debt-to-free-cash-flow ratio of 1.79 means it could theoretically pay off all its debt in less than two years. The Altman-Z score of 2.40 places it in the "grey zone," but still outperforming 62% of its industry peers. The bigger concern flagged in the report is that the number of shares outstanding has increased, which dilutes existing shareholders. Still, the balance sheet is not a red flag for a company growing at these rates. You can explore the financial details in the full fundamental analysis report here.
The Bigger Picture
The screen that picked LivaNova is not a one-off trick. It is a systematic way to find stocks where the business fundamentals are supporting a technical breakout, not the other way around. LivaNova scores well on both sides: strong growth metrics, decent profitability, a healthy enough balance sheet, and a chart that is setting up for a potential continuation move.
If you want to run this same screen yourself and see what other names are currently passing the filters, you can access the full results here.
Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. Always conduct your own research and consider your risk tolerance before making any trading decisions.
Read full article here »
View the Zacks #1 Rank List
LivaNova Plc (NASDAQ:LIVN) combines fundamental strength and technical timing for a potential breakout.
When investors talk about combining fundamental strength with technical timing, they are describing a strategy that uses financials to decide what to buy and charts to decide when to buy it. The screen that flagged LivaNova Plc (NASDAQ:LIVN) is built exactly on that principle. It starts by filtering for companies showing strong earnings and revenue growth, decent profitability, and a healthy balance sheet. Then it overlays a technical filter looking for stocks that are forming constructive chart patterns—think consolidations, tight price ranges, or bullish breakouts from bases. The idea is simple: you want a business that is genuinely expanding, but you also want to buy it at a moment when the market is starting to reward that expansion again. LivaNova currently checks both boxes.
[stock-image]
Recent Performance
LivaNova has been on a strong run. Over the past six months, the stock has gained roughly 35.6%, and over the last twelve months it has surged approximately 78.3%. That kind of performance places it among the better-performing stocks in the entire market, outperforming 91% of all names. More importantly, the gains have been spread steadily over the period rather than coming in a single parabolic spike, which suggests institutional accumulation rather than speculative frenzy.
The stock is currently trading near its 52-week high of $83.98, while the S&P 500 sits in the upper part of its own 52-week range but not at new highs. That relative strength—LivaNova leading, not just following the index—is a hallmark of the kind of leadership that growth investors look for. The short-term and long-term trends are both positive, and the stock is currently above its rising 20-, 50-, 100-, and 200-day moving averages.
Technical Setup
The technical rating is a perfect 10 out of 10, and the setup rating scores a 7. What does that mean in practice? The stock has been consolidating in a relatively tight range in recent weeks, with reduced volatility. That quiet period after a strong advance often represents a pause where big money accumulates shares without pushing the price higher too quickly. The setup report identifies a "Pocket Pivot" signal, a price/volume accumulation pattern that occurs when price moves up on volume exceeding the maximum down volume from the previous ten days. That is a classic momentum-buying signal.
The suggested entry point is a buy stop order just above the ten-day high at $83.99, with a stop loss placed below the ten-day low at $77.70. That puts the maximum risk on the trade at roughly 7.5%. For a stock with this kind of trend strength and a well-defined support zone between $71.33 and $72.36, that risk-reward profile is reasonable for a growth-oriented trade. You can review the full breakdown of the technical indicators in the detailed report here.
Fundamental Strength
The fundamental rating is a solid 6 out of 10, but the composition of that score is what matters for a growth investor. The growth sub-rating comes in at 7 out of 10, and it is driven by concrete numbers:
That sales and earnings trajectory is exactly what a growth screen is hunting for. The strategy we outlined at the start demands that the business itself is expanding, not just the stock price. LivaNova delivers on that front. The profitability rating of 7 is also encouraging: return on equity (8.85%), return on invested capital (8.01%), and operating margins (13.68%) all rank in the top quartile of the Health Care Equipment & Supplies industry.
Valuation and Health Considerations
No growth stock is without trade-offs. The valuation rating is a 4, which reflects a P/E ratio of 20.56—not cheap, but actually below the S&P 500 average of 27.43 and significantly cheaper than the industry median. The PEG ratio suggests that growth is not fully compensating for the multiple yet, but that is a common tension in growth investing: you pay up for quality, and the hope is that earnings growth will eventually justify the entry price.
On the health side, the rating is a 5. The company has a manageable debt-to-equity ratio of 0.24, and its debt-to-free-cash-flow ratio of 1.79 means it could theoretically pay off all its debt in less than two years. The Altman-Z score of 2.40 places it in the "grey zone," but still outperforming 62% of its industry peers. The bigger concern flagged in the report is that the number of shares outstanding has increased, which dilutes existing shareholders. Still, the balance sheet is not a red flag for a company growing at these rates. You can explore the financial details in the full fundamental analysis report here.
The Bigger Picture
The screen that picked LivaNova is not a one-off trick. It is a systematic way to find stocks where the business fundamentals are supporting a technical breakout, not the other way around. LivaNova scores well on both sides: strong growth metrics, decent profitability, a healthy enough balance sheet, and a chart that is setting up for a potential continuation move.
If you want to run this same screen yourself and see what other names are currently passing the filters, you can access the full results here.
Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. Always conduct your own research and consider your risk tolerance before making any trading decisions.
Read full article here »